Related Experiment Video
Updated: Jun 4, 2026

05:48
Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
[Amyloidosis in rheumatic diseases].
1Katedra i Klinika Chorób Wewnetrznych, Chorób Tkanki Łacznej i Geriatrii Gdańskiego Uniwersytetu Medycznego ul. Debinki 7, 80-211 Gdańsk.
Annales Academiae Medicae Stetinensis
|March 4, 2011
Summary
AA amyloidosis, a complication of rheumatic diseases, involves serum amyloid A (SAA) protein deposition. Preventing inflammation and early detection are key to managing this life-threatening condition.
Area of Science:
- Rheumatology
- Nephrology
- Immunology
Context:
- AA amyloidosis is a severe complication of chronic rheumatic diseases.
- It leads to increased mortality from organ failure and infection.
- Serum amyloid A (SAA) protein, an acute phase reactant produced by the liver, is the primary component of amyloid deposits.
Purpose:
- To present the pathogenesis of AA amyloidosis.
- To discuss current and emerging treatment strategies.
- To highlight the importance of understanding disease mechanisms for effective management.
Summary:
- Amyloidoses are characterized by extracellular amyloid fibril deposition.
- AA amyloidosis pathogenesis is intrinsically linked to chronic inflammation in rheumatic diseases.
- Effective anti-inflammatory therapy for rheumatic diseases is crucial for preventing AA amyloidosis.
Impact:
- Early detection and treatment can retard disease progression and potentially lead to amyloid deposit regression.
- Novel therapeutic approaches, including anti-TNF-alpha antibodies and eprodisate, show promise.
- Understanding SAA protein interactions offers new avenues for therapeutic intervention.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...